LAS VEGAS, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce that the September 15th edition of its Microdose Monthly newsletter will be highlighted by an exclusive interview with retired National Hockey League player and medicinal psychedelic advocate, Riley Cote.
In his four years with the Philadelphia Flyers, Cote developed a reputation throughout the NHL as one of the league’s most physically intimidating enforcers by racking up more than 50 on-ice fights and delivering countless bone chilling body checks to his opponents on a nightly basis. Off the ice, however, Cote found himself engaged in a fight with addiction and symptoms of PTSD that he was unable to gain an upper hand on and was steadily beginning to lose.
The Psychedelic Spotlight exclusive interview and article written by PSYC CEO, David Flores, dives attentively into Cote’s road to recovery post-retirement with the help of alternative medicines and therapeutic treatments, including microdosing psilocybin. The article also covers Cote’s current and ongoing venture with BodyChek Wellness which Cote has developed to help other individuals who are facing challenges similar to those he experienced overcome them and reclaim their health in the process.
Said Global Trac Solutions, Inc. CEO, David Flores: “I am incredibly grateful for this opportunity to share Riley’s story of how his mindful integration of psychedelics into his recovery process contributed to him overcoming his battle with addiction and symptoms of PTSD. In my opinion, sharing stories such as his are not only important in helping to lend credibility to the benefits of medicinal psychedelics, but also in the hope that his story may inspire others out there who may be struggling with some of the same conditions Riley was able to successfully overcome. Acknowledging that you are losing a battle with your mental health is most often the first, and most difficult, step towards recovery. And so if we in any way can help encourage or motivate individuals who may be out there struggling with their mental health to take the first step towards getting the help they need through the stories, education, and information we are providing, then we are, in my opinion, accomplishing something quite profound from a societal perspective .”
Last month, the Company announced that in response to its ability to effectively increase its production of original content focused on the emerging psychedelic industry, that it’s Microdose Monthly newsletter will be distributed to subscribers on a semi-monthly basis (15th and 25th of each month). The Company encourages those who have not done so already, to subscribe to Microdose Monthly by visiting www.psychedelicspotlight.com.
About Global Trac Solutions, Inc. (OTCPink: PSYC)
Global Trac Solutions is a diversified holding company dedicated to identifying new and emerging industries. By utilizing our years of business development expertise our diverse team of innovators continuously leverages our experience to effectively execute go-to-market strategies in order to position ourselves for rapid growth through the creation of an evolving business foundation to enhance profitability potential.
PSYC has expressed its intent and commitment to positioning itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities surrounding psychedelic inspired medicines. In conjunction with the FDA’s more open-minded approach to psychedelic medicines, and as several major U.S. cities continue to approve the decriminalization of psilocybin, investors are speculating that the psychedelic boom could be bigger than that of cannabis. PSYC is your source for current investment related news specific to psychedelic medicines and cutting-edge research improving overall health, moving this sector into the mainstream.
We believe in a forward-thinking approach that embraces groundbreaking new technology and innovations and through the vision of business development we intend to continue to evolve into these unchartered territories as the industry leaders of the future. We truly are the right TRAC to follow.
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "ongoing," "plan," "potential," "predict," "project," "should," "will," "would," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainty and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of all filings of the Company that are disclosed on the OTC Markets.com website.
Disclaimer: Global Trac Solutions, Inc. does not in any way encourage or condone the use, purchase, sale or transfer of any illegal substances, nor do we encourage or condone partaking in any unlawful activities. We support a harm reduction approach for the purpose of education and promoting individual and public safety. If you are choosing to use psychedelic substances, please do so responsibly.
Corporate Contact:
Global Trac Solutions, Inc. (PSYC)
www.globaltracsolutions.com
(702) 239-1919
info@globaltracsolutions.com
OTCPINK: PSYC
